Tokyo, March 3 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060794) titled 'Effectiveness and Feasibility of ChatGPT-Based Support for Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention' on March 2.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - Tokyo Healthcare University
Condition:
Condition - Ten patients with ACS who attended their first outpatient visit following PCI
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The purpose of this study is to use ChatGPT to support patients with ACS after PCI in addressing their post-discharge concerns and to evaluate its effectiveness.
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - Using ChatGPT
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Ten patients with ACS attending their first outpatient visit after PCI
Key exclusion criteria - Patients who are unable to provide informed responses due to communication difficulties and those who have been diagnosed with depression by a physician at the time of the outpatient visit.
Target Size - 15
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 02 Month 06 Day
Date of IRB - 2025 Year 12 Month 25 Day
Anticipated trial start date - 2026 Year 03 Month 06 Day
Last follow-up date - 2027 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069508
Disclaimer: Curated by HT Syndication.
